Synthesis anti-inflammatory and anticancer activity evaluation of some pyrazole and oxadiazole derivatives

Medicinal Chemistry Research

Volumn 21, Issue 10, 2012, Pages 3043-3052

  Sondhi, Sham M ^a   Kumar, Sandeep ^a   Kumar, Nikhil ^a   Roy, Partha ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY ROORKEE   (India)

Author keywords

Anti inflammatory activity; Anticancer; Oxadiazole derivatives; Pyrazole derivatives

Indexed keywords

2 [ 5 ( 2,5 DIMETHOXYPHENYL) 1 PHENYL 4,5 DIHYDRO 1H PYRAZOL 3 YL]PYRIDINE; 2 [ 5 ( 2,5 DIMETHOXYPHENYL) 4,5 DIHYDRO 1H PYRAZOL 3 YL]PYRIDINE; 2,5 DIMETHOXYBENZALDEHYDE; 3 [ 5 ( 2,5 DIMETHOXYPHENYL) 1 PHENYL 4,5 DIHYDRO 1H PYRAZOL 3 YL]PYRIDINE; 3 [ 5 ( 2,5 DIMETHOXYPHENYL) 4,5 DIHYDRO 1H PYRAZOL 3 YL]PYRIDINE; 4 [ 5 ( 2,5 DIMETHOXYPHENYL) 1 PHENYL 4,5 DIHYDRO 1H PYRAZOL 3 YL]PYRIDINE; 4 [ 5 ( 2,5 DIMETHOXYPHENYL) 4,5 DIHYDRO 1H PYRAZOL 3 YL]PYRIDINE; ANTIINFLAMMATORY AGENT; BENZALDEHYDE DERIVATIVE; CHALCONE DERIVATIVE; CYCLOHEXIMIDE; CYCLOPHOSPHAMIDE; FLUOROURACIL; HYDRAZINE; IBUPROFEN; N' HYDROXYISONICOTINAMIDINE; N' HYDROXYPICOLINAMIDINE; N' HYDROXYPYRAZINE 2 CARBOXAMIDINE; N,N DIMETHYL 4 [ 1 PHENYL 3 (PYRIDIN 2 YL) 4,5 DIHYDRO 1H PYRAZOL 5 YL]BENZENAMINE; N,N DIMETHYL 4 [ 3 (PYRIDIN 2 YL) 4,5 DIHYDRO 1H PYRAZOL 5 YL]BENZENAMINE; N,N DIMETHYL 4 [ 3 (PYRIDIN 3 YL) 4,5 DIHYDRO 1H PYRAZOL 5 YL]BENZENAMINE; N,N DIMETHYL 4 [ 3 (PYRIDIN 4 YL) 4,5 DIHYDRO 1H PYRAZOL 5 YL]BENZENAMINE; NICOTINAMIDE DERIVATIVE; OXADIAZOLE DERIVATIVE; PHENYLHYDRAZINE; PYRAZINE DERIVATIVE; PYRAZOLE DERIVATIVE; PYRIDINE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VANILLIN;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; CRYSTAL STRUCTURE; CYTOTOXICITY; DRUG MECHANISM; DRUG SCREENING; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; MASS SPECTROMETRY; MICROWAVE IRRADIATION; NONHUMAN; PAW EDEMA; POLYMERIZATION; RAT;

EID: 84866359445     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-011-9850-7     Document Type: Article

References (53)

1. Abdellatif KRA, Chowdhury MA, Dong Y, Knaus EE (2008) Diazen- 1-ium-1,2-diolated nitric oxide donor ester prodrugs of 1-(4- methanesulfonylphenyl)-5-aryl-1H-pyrazol-3-carboxylic acids: Synthesis, nitric oxide release studies and anti-inflammatory activities. Bioorg Med Chem 16:6528-6534
2. Abdel-Wahab BF, Abdel-Aziz HA, Ahmed EM (2009) Synthesis and antimicrobial evaluation of 1-(benzofuran-2-yl)-4-nitro-3-arylbutan- 1-ones and 3-(benzofuran-2-yl)-4,5-dihydro-5-aryl-1-[4- (aryl)-1,3-thiazol-2-yl]-1H- pyrazoles. Eur J Med Chem 44: 2632-2635
3. Abu-Zaied MA, El-Telbani EM, Elgemeie GH, Nawwar GAM (2011) Synthesis and in vitro anti-tumor activity of new oxadiazole thioglycoside. Eur J Med Chem 46:229-235
4. Bakht MA, Yar MS, Abdel-Hamid SG, Qasoumi A, Samad A (2010) Molecular properties prediction, synthesis and antimicrobial activity of some newer oxadiazole derivatives. Eur J Med Chem 45:5862-5869
5. Bala S, Kamboj S, Kumar A (2010) Heterocyclic 1,3,4-oxadiazole compounds with diverse biological activities. J Pharm Res 3:2993-2997
6. Brown JR, DuBois RN (2005) COX-2: a molecular target for colorectal cancer prevention. J Clin Oncol 23:2840-2855
7. Burguete A, Pontiki E, Hadjipavlou-Litina D, Villar R, Vicente E, Solano B, Ancizu S, Pérez-Silanes S, Aldana I, Monge A (2007) Synthesis and anti-inflammatory/antioxidant activities of some new ring substituted 3-phenyl-1-(1,4-di-N-oxide quinoxalin-2-yl)-2-propen-1-one derivatives and of their 4, 5-dihydro-(1H)-pyrazole analogues. Bioorg Med Chem Lett 17:6439-6443
8. Chandra T, Garg N, Lata S, Saxena KK, Kumar A (2010) Synthesis of substituted acridinyl pyrazoline derivatives and their evaluation for anti-inflammatory activity. Eur J Med Chem 45:1772-1776
9. Chavan RS, More HN (2011) Synthesis, characterization and evaluation of analgesic and anti-inflammatory activities of some novel 2-(4,5-dihydro-1H- pyrazol-3-yl)-3-phenyl-1H-indole. J Pharm Res 4:1575-1578
10. Cheng SY, Wen ZH, Chiou SF, Hsu CH, Wang SK, Dai HF, Chiang MY, Duh CY (2008) Durumolides A-E, anti-inflammatory and antibacterial cembranolides from the soft coral Lobophytum durum. Tetrahedron 64:9698-9704
11. Crespo MI, Gracia J, Puig C, Vega A, Bou J, Beleta J, DomeAnech T, Ryder H, Segarra V, Palacios JM (2000) Synthesis and biological evaluation of 2,5-dihydropyrazolo[4,3-c]quinolin- 3-ones, a novel series of PDE 4 inhibitors with low emetic potential and antiasthmatic properties. Bioorg Med Chem Lett 10:2661-2664
12. Cunico W, Cechinel CA, Bonacorso HG, Martins MAP, Zanatta N, Souza MVN, Freitas IO, Soares RPP, Krettli AU (2006) Antimalarial activity of 4-(5-trifluoromethyl-1H-pyrazol-1-yl)- chloroquine analogues. Bioorg Med Chem Lett 16:649-653
13. Efange SMN, Tu Z, Hohenberg KV, Francesconi L, Howell RC, Rampersad MV, Todaro LJ, Papke RL, Kung MP (2001) 2-(2-piperidyl)- and 2-(2-pyrrolidyl) chromans as nicotine agonists: synthesis and preliminary pharmacological characterization. J Med Chem 44:4704-4715
14. El-Enany M, El-Meligie SEM, Abdou NA, El-Nassan HB (2010) Synthesis and antimicrobial activity of some 3,5-diaryl-4, 5-dihydropyrazole derivatives. Orient J Chem 26:1265-1270
15. El-Sabbagh OI, Baraka MM, Ibrahim SM, Pannecouque C, Andrei G, Snoeck R, Balzarini J, Rashad AA (2009) Synthesis and antiviral activity of new pyrazole and thiazole derivatives. Eur J Med Chem 44:3746-3753
16. Flipo M, Desroses M, Lecat-Guillet N, Diri B, Carette X, Leroux F, Piveteau C, Demirkaya F, Lens Z, Rucktooa P, Villeret V, Christophe T, Jeon HK, Locht C, Brodin P, Deprez B, Baulard AR, Willand N (2011) Ethionamide boosters: synthesis, biological activity, and structure activity relationships of a series of 1,2,4-oxadiazole EthR inhibitors. J Med Chem 54:2994-3010
17. Grosch S, Maier TJ, Schiffmann S, Geisslinger G (2006) Cyclooxygenase- 2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors. J Natl Cancer Inst 98:736-747
18. Harris RE (2009) Cyclooxygenase-2 (cox-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung. Inflammopharmacology 17:55-67
19. Harris RE, Beebe-Donk J, Alshafie GA (2007) Cancer chemoprevention by cyclooxygenase 2 (COX-2) blockade: results of case control studies. Subcell Biochem 42:193-212
20. Harris RE, Beebe-Donk J, Alshafie GA (2008) Similar reductions in the risk of human colon cancer by selective and nonselective cyclooxygenase-2 (COX-2) inhibitors. BMC Cancer 8:237-242
21. Iniguez MA, Punzon C, Cacheiro-Llaguno C, Diaz-Munoz MD, Duque J, Cuberes R, Alvarez I, Andres EM, Buxens J, Buschmann H, Vela JM, Fresno M (2010) Cyclooxygenaseindependent inhibitory effects on T cell activation of novel 4,5- dihydro-3 trifluoromethyl pyrazole cyclooxygenase-2 inhibitors. Int Immunopharmacol 10:1295-1304
22. Katade S, Phalgune U, Biswas S, Wakharkar R, Deshpande N (2008) Microwave studies on synthesis of biologically active chalcone derivatives. Indian J Chem Sect B Org Chem Med Chem 47B:927-931
23. Katarzyna G (2009) Synthesis and antibacterial activity of novel pyridine and pyrazine derivatives obtained from amidoximes. J Heterocycl Chem 46:1271-1279
24. Khalil NSAM (2009) A facile synthesis, structure, and antimicrobial evaluation of novel 4-arylhydrazono-5-trifluoromethyl-2, 4-dihydropyrazol-3- ones, their N- and N, O-bis-b-D- glucosides. Carbohydr Res 344:1654-1659
25. Koryakova AG, Ivanenkov YA, Ryzhova EA, Bulanova EA, Karapetian RN, Mikitas OV, Katrukha EA, Kazey VI, Okun I, Kravchenko DV, Lavrovsky YV, Korzinov OM, Ivachtchenko AV (2008) Novel aryl and heteroaryl substituted N-[3-(4- phenylpiperazin-1-yl)propyl]-1,2,4-oxadiazole-5-carboxamides as selective GSK-3 inhibitors. Bioorg Med Chem Lett 18:3661-3666
26. Kumar D, Patel G, Chavers AK, Chang KH, Shah K (2011) Synthesis of novel 1,2,4-oxadiazoles and analogues as potential anticancer agents. Eur J Med Chem 46:3085-3092
27. Liu XH, Cui P, Song BA, Bhadury PS, Zhua HL, Wang SF (2008) Synthesis, structure and antibacterial activity of novel 1-(5-substituted-3-substituted-4, 5-dihydropyrazol-1-yl)ethanone oxime ester derivatives. Bioorg Med Chem 16:4075-4082
28. Liu XH, Liu JX, Bai LS, Lan GL, Pan CX (2010) Novel dihydropyrazole derivatives linked with 4H-chromene. Microwave- promoted synthesis and antibacterial activity. Lett Org Chem 7:487-490
29. Lv PC, Li HQ, Sun J, Zhou Y, Zhu HL (2010) Synthesis and biological evaluation of pyrazole derivatives containing thiourea skeleton as anticancer agents. Bioorg Med Chem 18:4606-4614
30. Manjunatha K, Poojary B, Lobo PL, Fernandes J, Kumari NS (2010) Synthesis and biological evaluation of some 1,3,4-oxadiazole derivatives. Eur J Med Chem 45:5225-5233
31. Markwalder JA, Arnone MR, Benfield PA, Boisclair M, Burton CR, Chang CH, Cox SS, Czerniak PM, Dean CL, Doleniak D, Grafstrom R, Harrison BA, Kaltenbach RF, Nugiel DA, Rossi KA, Sherk SR, Sisk LM, Stouten P, Trainor GL, Worland P, Seitz SP (2004) Synthesis and biological evaluation of 1-aryl-4, 5-dihydro-1H-pyrazolo[3,4-d]pyrimidin-4-one inhibitors of cyclindependent kinases. J Med Chem 47:5894-5911
32. Mishra N, Arora P, Kumar B, Mishra LC, Bhattacharya A, Awasthi SK, Bhasin VK (2008) Synthesis of novel substituted 1,3-diaryl propenone derivatives and their antimalarial activity in vitro. Eur J Med Chem 43:1530-1535
33. Monks A, Scudiero D, Skehan P, Shoemaker R, Paull K, Vistica D, Hose C, Langley J, Cronise P (1991) Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J Natl Cancer Inst 83:757-766
34. Narwade SK, Karale BK, Jagdhani SG, Chaudhari CS, Rindhe SS (2008) Synthesis and antimicrobial screening of (1-(2,4-dichlorophenyl)- 1H-pyrazol-4yl (2-hydroxyphenyl) methanone and 2- (1-2,4-dichlorophenyl)-1H-pyrazol-4yl) benzo [d] oxazole. Orient J Chem 24:1029-1034
35. Sahoo BM, Kumar BVVR, Kumari BUBP (2011) Synthesis characterisation and biological evaluation of novel oxadiazole derivatives. Int J Pharm Sci Research 2:344-350
36. Settimoa AD, Settimoa FD, Marini AM, Primofiore G, Salerno S, Violab G, Vie LD, Magnob SM (1998) Synthesis, DNA binding and in vitro antiproliferative activity of purinoquinazoline, pyridopyrimidopurine and pyridopyrimidobenzimidazole derivatives as potential antitumor agents. Eur J Med Chem 33:685-696
37. Severina IS, Pyatakova NV, Bussygina OG, Mikhailitsyn FS, Khropov YV (2002) Inhibition of nitric oxide-dependent activation of soluble guanylyl cyclase by the antimalarial drug, artemisinin. Eur J Pharmacol 438:69-73
38. Shen HC, Ding FX, Wang S, Deng Q, Zhang X, Chen Y, Zhou G, Xu S, Chen HS, Tong X, Tong V, Mitra K, Kumar S, Tsai C, Stevenson AS, Pai LY, Alonso-Galicia M, Chen X, Soisson SM, Roy S, Zhang B, Tata JR, Berger JP, Colletti SL (2009) Discovery of a highly potent, selective, and bioavailable soluble epoxide hydrolase inhibitor with excellent ex vivo target engagement. J Med Chem 52:5009-5012
39. Skehan P, Storeng R, Scudiero D, Monks A, McMohan J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR (1990) New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 82:1107-1112
40. Sondhi SM, Dinodia M, Singh J, Rani R (2007) Heterocyclic compounds as anti-inflammatory agents. Curr Bioactive Compd 3:91-108
41. Sondhi SM, Rani R, Roy P, Agrawal SK, Saxena AK (2009) Microwave-assisted synthesis of N-substituted cyclic imides and their evaluation for anticancer and anti-inflammatory activities. Bioorg Med Chem Lett 19:1534-1538
42. Sondhi SM, Singh J, Rani R, Gupta PP, Agarwal SK, Saxena AK (2010a) Synthesis, anti-inflammatory and anticancer activity evaluation of some novel acridine derivatives. Eur J Med Chem 45:555-563
43. Sondhi SM, Rani R, Singh J, Roy P, Agarwal SK, Saxena AK (2010b) Solvent free synthesis, anti-inflammatory and anticancer activity evaluation of tricyclic and tetracyclic benzimidazole derivatives. Bioorg Med Chem Lett 20:2306-2310
44. Sondhi SM, Rani R, Roy P, Agarwal SK, Saxena AK (2010c) Conventional and microwave assisted synthesis of small molecule based biologically active heterocyclic amidine derivatives. Eur J Med Chem 45:902-908
45. Sun LC, Weili L, Sprengeler PA, Somoza JR, Janc JW, Sperandio D, Spencer JR, Green MJ, Mcgrath ME (2006) Design of novel, potent, and selective human b-tryptase inhibitors based on a-keto-[1,2,4]-oxadiazoles. Bioorg Med Chem Lett 16:4036-4040
46. Sunduru N, Agarwal A, Katiyar SB, Nishi GN, Guptab S, Chauhana PMS (2006) Synthesis of 2,4,6-trisubstituted pyrimidine and triazine heterocycles as antileishmanial agents. Bioorg Med Chem 23:7706-7715
47. Veerasamy R, Sivadasan S, Karupiah S, Dhanaraj SA (2010) QSAR study of substituted 1,3,4-oxadiazole naphthyridines as HIV-1 integrase inhibitors. Eur J Med Chem 45:2791-2797
48. Winter CA, Risley EA, Nuss GW (1962) Carrageenin-induced edema in hind paw of rat as an assay for anti-inflammatory drugs. Proc Soc Exp Biol Med 111:544-547
49. Xiao D, Deguchi A, Gundersen GG, Oehlen B, Arnold L, Weinstein IB (2006) The sulindac derivatives OSI-461, OSIP486823, and OSIP487703 arrest colon cancer cells in mitosis by causing microtubule depolymerization. Mol Cancer Ther 5:60-67
50. Zareef M, Iqbal R, Gamboa DN, Rodrigues J, Zaidi JH, Arfan M, Supuran CT (2007) Synthesis and antimalarial activity of novel chiral and achiral benzenesulfonamides bearing 1,3,4-oxadiazole moieties. J Enzym Inhib Med Chem 22:301-308
51. Zhang XM, Qiu M, Sun J, Zhang YB, Yang YS, Wang XL, Tang JF, Zhu HL (2011) Synthesis, biological evaluation, and molecular docking studies of 1,3,4-oxadiazole derivatives possessing 1,4-benzodioxan moiety as potential anticancer agents. Bioorg Med Chem 19:6518-6524
52. Zheng QZ, Zhang XM, Xu Y, Cheng K, Jiao QC, Zhu HL (2010) Synthesis, biological evaluation, and molecular docking studies of 2-chloropyridine derivatives possessing 1,3,4-oxadiazole moiety as potential antitumor agents. Bioorg Med Chem 18: 7836-7841
53. Ziedan NI, Stefanelli F, Fogli S, Westwell AD (2010) Design, synthesis and pro-apoptotic antitumour properties of indolebased 3,5-disubstituted oxadiazoles. Eur J Med Chem 45: 4523-4530